The US FDA and CMS have launched the RAPID pathway to accelerate Medicare coverage for certain breakthrough medical devices by aligning regulatory and reimbursement processes earlier in development.
Moving Biotech secures FDA Fast Track for 4P004 targeting knee osteoarthritis with synovitis after failure of at least two ...
Polaryx Therapeutics, Inc. (Nasdaq: PLYX), a clinical-stage biotechnology company developing disease-modifying therapies for rare pediatric LSDs, today announced that the U.S. Food and Drug ...
A new AI partnership and a Medicare device fast-track highlight ongoing changes in healthcare delivery. OZMOSI and Planview are combining structured clinical datasets with AI-driven portfolio planning ...
The FDA Modernization Act of 1997 established the Fast Track designation to expedite developing and reviewing new drugs designed to fill unmet medical needs and treat serious conditions. The FDA Fast ...
Received FDA Fast Track Designation for pevifoscorvir sodium for the treatment of chronic hepatitis B virus infectionHBeAg- cohort sample size ...
STAFFORD, Texas, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results